Cargando…

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research

Alzheimer's Disease (AD), the leading cause of senile dementia, is a progressive neurodegenerative disorder affecting millions of people worldwide and exerting tremendous socioeconomic burden on all societies. Although definitive diagnosis of AD is often made in the presence of clinical manifes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Weiqi, Xie, Fang, Zuo, Chuantao, Guan, Yihui, Huang, Yiyun Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134674/ https://www.ncbi.nlm.nih.gov/pubmed/34025386 http://dx.doi.org/10.3389/fnagi.2021.624330

Ejemplares similares

Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
por: Colom, Matthieu, et al.
Publicado: (2019)

Associations of [(18)F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism
por: Lu, Jiaying, et al.
Publicado: (2020)

PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [(18)F]DPA714
por: Hu, Wei, et al.
Publicado: (2020)

Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
por: Zhang, Lingling, et al.
Publicado: (2021)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
por: Jiang, Donglang, et al.
Publicado: (2019)

Distinct cerebral (18)F-FDG PET metabolic patterns in anti-N-methyl-D-aspartate receptor encephalitis patients with different trigger factors
por: Ge, Jingjie, et al.
Publicado: (2021)

PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022)

Crystallographic study of PET radiotracers in clinical evaluation for early diagnosis of Alzheimers
por: Altomare, Angela, et al.
Publicado: (2014)

Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use
por: Shaw, Robert C., et al.
Publicado: (2020)

PET Imaging Radiotracers of Chemokine Receptors
por: Alluri, Santosh R., et al.
Publicado: (2021)

New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms
por: Fortunati, Emilia, et al.
Publicado: (2022)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021)

Development of a Radiotracer for PET Imaging of the SNAP Tag
por: Li, Xinling, et al.
Publicado: (2022)

The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
por: Santo, Giulia, et al.
Publicado: (2022)

Data sharing in neuroimaging research
por: Poline, Jean-Baptiste, et al.
Publicado: (2012)

PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications
por: Alongi, Pierpaolo, et al.
Publicado: (2014)

Editorial: Utilization of Hybrid PET/MR in Neuroimaging
por: Tahmasian, Masoud, et al.
Publicado: (2015)

Diagnostic value of blood thiamine metabolites in Alzheimer’s disease examined by (11)C-PiB PET scanning
por: Chen, Zhichun, et al.
Publicado: (2017)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

PET-Specific Parameters and Radiotracers in Theoretical Tumour Modelling
por: Jennings, Matthew, et al.
Publicado: (2015)

Folate-Based Radiotracers for PET Imaging—Update and Perspectives
por: Müller, Cristina
Publicado: (2013)

PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives
por: Alluri, Santosh Reddy, et al.
Publicado: (2020)

A review of β-amyloid neuroimaging in Alzheimer's disease
por: Adlard, Paul A., et al.
Publicado: (2014)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
por: Kecheliev, Vasil, et al.
Publicado: (2022)

Conventional machine learning and deep learning in Alzheimer's disease diagnosis using neuroimaging: A review
por: Zhao, Zhen, et al.
Publicado: (2023)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study
por: Ju, Zizhao, et al.
Publicado: (2022)

PT572. Advances in the Development of Tau PET Radiotracers and Their Clinical Applications
por: Yanai, Kazuhiko, et al.
Publicado: (2016)

Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging
por: Liu, Sidong, et al.
Publicado: (2016)

Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)
por: Jackson, Isaac M., et al.
Publicado: (2020)

Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging
por: Singh, Nisha, et al.
Publicado: (2018)

The next era of renal radionuclide imaging: novel PET radiotracers
por: Werner, Rudolf A., et al.
Publicado: (2019)

Cross-Coupling Reactions as Valuable Tool for the Preparation of PET Radiotracers
por: Pretze, Marc, et al.
Publicado: (2011)

Rationalizing the Binding Modes of PET Radiotracers Targeting the Norepinephrine Transporter
por: Tutov, Anna, et al.
Publicado: (2023)

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

ANSH: Multimodal Neuroimaging Database Including MR Spectroscopic Data From Each Continent to Advance Alzheimer’s Disease Research
por: Mandal, Pravat K., et al.
Publicado: (2020)

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
por: Li, Li, et al.
Publicado: (2022)

Using CT Data to Improve the Quantitative Analysis of (18)F-FBB PET Neuroimages
por: Segovia, Fermín, et al.
Publicado: (2018)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htjkgu031rglo8l2ijmo4e5tbd